Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by gram-negative bacteria

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 12, 2010, Pages 2645-2649

  Rattanaumpawan, Pinyo ^a   Lorsutthitham, Jintana ^a   Ungprasert, Puangpaka ^a   Angkasekwinai, Nasikarn ^a   Thamlikitkul, Visanu ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Colistin; Healthcare associated pneumonia; Inhaled therapy

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; COLISTIMETHATE; COLISTIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SODIUM CHLORIDE; SULPERAZON;

ACINETOBACTER BAUMANNII; ADJUVANT THERAPY; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BRONCHOSPASM; CLINICAL DECISION MAKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MULTIDRUG RESISTANCE; NEBULIZATION; NEUROTOXICITY; OUTCOME ASSESSMENT; PHYSICIAN; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME; VENTILATOR ASSOCIATED PNEUMONIA;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COLISTIN; CROSS INFECTION; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; PNEUMONIA, BACTERIAL; PNEUMONIA, VENTILATOR-ASSOCIATED; TREATMENT OUTCOME;

EID: 78149480085     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq360     Document Type: Article

References (10)

1. Edwards JR, Peterson KD, Andrus ML et al. National Healthcare Safety Network (NHSN) Report, data summary for 2006 through 2007, issued November 2008. Am J Infect Control 2008; 36: 609-26.
2. Danchaivijitr S, Dhiraputra C, Santiprasitkul S et al. Prevalence and impacts of nosocomial infections in Thailand 2001. J Med Assoc Thai 2005; 88 Suppl 10: S1-9.
3. Danchaivijitr S, Judaeng T, Sripalakij S et al. Prevalence of nosocomial infection in Thailand 2006. J Med Assoc Thai 2007; 90: 1524-9.
4. Kwa AL, Loh C, Low JG et al. Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Clin Infect Dis 2005; 41: 754-7.
5. Falagas ME, Kasiakou SK, Tsiodras S et al. The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature. Clin Med Res 2006; 4: 138-46.
6. Michalopoulosa A, Fotakisa D, Virtzilia S et al. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study. Respir Med 2008; 102: 407-12.
7. Gursel G, Demirtas S. Value of APACHE II, SOFA and CPIS scores in predicting prognosis in patients with ventilator-associated pneumonia. Respiration 2006; 73: 503-8.
8. Schwartz BS, Warren MR, Barkley FA et al. Microbiological and pharmacological studies of colistin sulfate and sodium colistinmethanesulfonate. Antibiot Annu 1959; 7: 41-60.
9. Bergen PJ, Li J, Rayner CR et al. Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa. Antimicrob Agents Chemother 2006; 50: 1953-8.
10. Dotter EC, Furuno JP, Harris AD et al. Outcomes associated with inhaled polymyxin B for treatment of Acinetobacter baumannii and Pseudomonas aeruginosa respiratory tract infections. In: Abstracts of the Forty-ninth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 2009. Abstract K286. American Society for Microbiology, Washington, DC, USA.